Position in REGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,603,962,281
+$6,424,411 QoQ
Shares Held
4,664,478
+0.1% QoQ
Ownership
4.45%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 10.842949629090329.ToString("F0")%
Shared 0.8631405271929679.ToString("F0")%
None 88.2939098437167.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STATE STREET CORP holds $30,287,966,567 across 421 Biotechnology names. REGN ranks #2 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,730,139 | $5,237,976,269 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
4,664,478 | $3,603,962,281 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,322,698 | $1,099,381,087 | |
| 4 | INSM |
INSMED Inc
|
5,551,699 | $907,813,820 | |
| 5 | INCY |
Incyte Corp
|
9,641,384 | $907,447,062 | |
| 6 | MRNA |
Moderna, Inc.
|
14,861,409 | $754,959,577 | |
| 7 | RPRX |
Royalty Pharma plc
|
10,989,851 | $527,183,152 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
16,186,613 | $448,369,180 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,603,962,281 | 4,664,478 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,597,537,870 | 4,660,808 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,637,733,956 | 4,691,223 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,536,801,050 | 4,832,002 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,037,745,427 | 4,789,659 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,442,148,806 | 4,832,239 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,153,603,180 | 4,902,404 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,088,169,710 | 4,841,127 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,659,941,534 | 4,841,548 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,304,719,740 | 4,901,251 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $3,974,161,073 | 4,829,106 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,586,139,729 | 4,990,870 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,020,937,458 | 4,893,616 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,579,228,918 | 4,960,885 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $3,480,005,222 | 5,051,759 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $3,032,872,267 | 5,130,635 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,579,728,662 | 5,125,467 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,031,183,589 | 4,799,822 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,808,038,225 | 4,640,005 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,522,766,554 | 4,516,716 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,151,509,995 | 4,547,301 | Shares | Defined | 2021-07-09 | |
| 2020-12-31 | $2,266,455,973 | 4,691,387 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $2,607,196,621 | 4,657,538 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $2,838,645,877 | 4,551,665 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,766,307,530 | 3,617,333 | Shares | Defined | 2020-06-19 | |
| No filing history on record for this holder in this stock. | ||||||